Background: The ideal nomenclature of atopic dermatitis (AD) / atopic eczema (AE)
and Wise first coined "atopic dermatitis" as a footnote in the "1933 Year Book of Dermatology and Syphilology".
The term "atopic" was included in the terminology as it emerged that some individuals with AD/AE reacted on the skin to allergens. Further, the term "atopy" (Greek for "out of place") was introduced by Coca and Cooke in 1923 as part of a new definition on hypersensitivities, categorized with abnormal immunological patterns. However, the definition of the term atopy is controversial. Some decades ago, atopy was defined by the associated diseases, as an "inheritable tendency to develop the atopic diseases, namely hay fever, bronchial asthma, and atopic dermatitis." Presently, the World Allergy Organization defines atopy as "a personal and/or familial tendency, usually in childhood or adolescence, to become sensitized and produce Immunoglobulin E antibodies in response to ordinary exposure to allergens, usually proteins."
Given the lack of a clear definition, some prefer to exclude the term "atopy" and use "eczema" as the standalone disease nomenclature.
A major question has been whether dermatitis, eczema, and other terminology represent the same entity. A pioneering description of AD/AE or "constitutional prurigo" was provided by Hebra as a chronic, recurrent skin disorder, characterized by intensely pruritic papules and nodules on the trunk and limbs. 4 Later, it was accepted that infantile eczema and neurodermatitis/diathetic prurigo in children and adults represented the same disease. During the second half of the twentieth century, the term "constitutional eczema" was preferred by French dermatologists, "neurodermatitis" by Germanspeaking dermatologists, and "atopic eczema" by British dermatologists. 4 Presently, many use the terms dermatitis, AD, and eczema syn- | 2027 "atopic dermatitis" and "eczema" were the most common. 6 In MED-LINE (PubMed), 64.4% of publications addressing AD/AE used the term "atopic dermatitis," 46.9% "eczema" and only 7.5% "atopic eczema." Few publications used the terminology "childhood eczema,"
"flexural eczema," "infantile eczema," "atopic neurodermatitis," or "Besnier's prurigo." AD was also the most frequently used term in studies of adults and children, humans and animals, males and females, followed by "eczema" alone. AD was the most commonly used term in the highest impact-factor dermatology and allergy/immunology journals, whereas "eczema" was the most commonly used term in the pediatric and internal medicine literature. "Atopic eczema" was the least commonly used of the three terms in all of these subgroups. It is imperative that harmonization of the nomenclature for AD includes the many different specialties that manage AD and the broader healthcare provider community.
There appear to be regional differences with respect to the preferred terminology. AD was the most commonly used term in publications written in English, Japanese, Spanish, 6 and Korean (unpublished data), whereas "eczema" was most often used in publications written in French, German, Italian, and Russian. "Atopic eczema" was the least commonly used of the three terms in all of these languages. These regional differences underscore the imperative for international consensus on AD nomenclature.
| Lay population
"Eczema" is the dominant terminology used by the lay population.
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A recent study found that "eczema" and its common misspellings accounted for 84% of combined monthly searches on the Google, Bing, Yahoo, and Baidu Internet search engines. 11 AD and AE accounted for only 14% and 2% of searches, respectively. Again, there appeared to be considerable regional differences in the popularity of terminology. "Eczema" was the most popular terminology searched for in English, Russian, Turkish, and Japanese, and "atopic eczema" was the least popular of the three terms by far. Consistent with this trend, the patient organizations for AD/AE in the USA and UK are titled the National Eczema Association and National Eczema Society, respectively, and even the International Eczema Council was so named to be understood by the lay public.
| Clinical terminology
Disparate terms are also used for AD/AE in the clinical setting, which has a number of important and potentially problematic ramifications. Many clinicians treat the term "eczema" as a morphological descriptor for characteristic cutaneous lesions and histologic alterations in biopsy sections; this is the approach of the American Academy of Dermatology. 12 Others would use the term "spongiotic dermatitis" to describe the same histologic pattern. In fact, this use of "eczema" includes multiple morphologies, ranging from the acute, subacute, and chronic ill-defined lesions present in AD/AE. Moreover, this use of "eczema" is far broader than the initial intent of the term in its original use for acute vesicular or bullous lesions.
The term "atopic dermatitis" may be more appropriate, as it frames the multiple disease morphologies with a specific attribution to an atopic phenotype or etiology. On the other hand, many clinicians may use the term "eczema" as a synonym for AD/AE as per the lay public and/or the consensus of the World Allergy Organization. 13 The World Allergy Organizations proposed that the term eczema should replace the use of terms AD and AE and that AE should refer to eczema in a person of the atopic constitution. 13 These recommendations have not been widely followed. The disparate use of terminology may be confusing for both clinicians and patients alike.
| International classification of disease codes
Importantly, the terms "atopic dermatitis" and "eczema" are associated with different International Classification of Disease (ICD) codes (ICD-9: 691.8 vs 692.9; ICD-10: L20.x vs L30.9, respectively). However, the ICD-9 code 692.9 is meant to be used for unspecified contact dermatitis; the ICD-10 code L30.9 is meant to be used even more broadly for unspecified dermatitis. Thus, when providers type the term "eczema" into an electronic health record, the software may apply incorrect ICD codes. The incorrect use of ICD billing codes might result in lack of reimbursement for certain medications and/or services by payers.
The incorrect use of ICD codes also has major ramifications for epidemiology and health services research of AD/AE. A recent study examined the validity of the ICD-9 codes 691.8 (AD) and 692.9
(eczema). 14 atopic disease prefix, that is, AD or AE. Thus, the consensus of the IEC is to recommend against the use of the term "eczema" owing to its imprecision, and disparate and confusing real-world use. We were unable to reach consensus for preferred use of the term "atopic dermatitis" vs "atopic eczema," although AD was more commonly preferred and had the highest rate of acceptability. Our recommendation is to standardize the disease nomenclature with use of the terms "atopic dermatitis" or "atopic eczema" in clinical trials, scientific literature, presentations, and patient education.
The consensus to not use the term "eczema" has important ramifications for patient education. "Eczema" is the most common lay term for AD/AE. Currently, clinical history taking and survey-based research studies for AD/AE require use of the term "eczema." Indeed, a recent multicenter validation study found that self-or caregiverreported "eczema or skin allergy" had good sensitivity and positive predictive value. 17 On the other hand, there are several etiologies of eczematous reactions, and patients may mistakenly assume that they have AD/AE when, in fact, they may have another form of eczema, such as stasis or nummular eczema or contact eczema. Thus, patient counseling for AD/AE must strike a balance between use of familiar lay terminology "eczema" and educating patients about their specific etiology of disease. We therefore recommend that the term "atopic"
should be introduced to patients with AD/AE, rather than just sharing the diagnostic terms "eczema" or "dermatitis."
The transformation to consistency will not be an easy one. The term "eczema" is shorter and easier to use in conversation with patients (although more difficult to spell), and a shift to AD or AE would require patient discussions to clarify the imprecision of the term "eczema." It may also be difficult for an organization focused on AD that includes "eczema" in its title to change its name to support this unification, especially until a widespread movement is underway to shift to public utilization of the terms "atopic dermatitis" or "atopic eczema." Nevertheless, there is a solid rationale and partial consensus for a more precise name for this disorder by at least using the atopic prefix prior to the terms eczema or dermatitis.
We encourage physicians in all specialties and in every country to shift their own use of terminology away from eczema alone to AD or AE in writing, presentations, and discussions with patients and other healthcare personnel as a first step.
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